why choose us

First received: November 9, 2022

Clinical Trial: The Potential Role of sRAGE, KL-6, and SP-D as Prognostic Factors in Children With COVID-19

Study Status: Completed

Recruit Status: Completed

Condition: SARS CoV 2 Infection
Alveolar; Injury
Children
Pneumonia, Viral

Study Type: Observational [Patient Registry]


Official Title: The Potential Role of Receptor for Advanced Glycation End-Products, Serum, Krebs Von Den Lungen-6, and Surfactant Protein D as Prognostic Factors in Children With Severe Acute Respiratory Syndrome (SA

Brief Summary: COVID-19 causes a wide spectrum of clinical illness, from upper respiratory symptoms to severe respiratory failure and death. Several plasma biomarkers -such as IL-6, C-reactive protein (CRP), D-dimer, the neutrophil-to-lymphocyte ratio, and ferritin, among others- have been studied as markers of disease severity and prognosis. Besides, as alveolar damage biomarkers such as Surfactant protein D (SP-D), Krebs von den Lungen-6 (KL-6), and soluble Receptor for Advanced Glycation end products (sRAGE) can be used in…

Read more